Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
28.19
+1.32 (4.91%)
At close: Feb 24, 2026, 4:00 PM EST
28.75
+0.56 (1.99%)
After-hours: Feb 24, 2026, 7:38 PM EST

HRMY Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
158.69145.49128.85181.4734.6
Depreciation & Amortization
25.3424.1124.3623.3918.84
Other Amortization
0.650.72.271.662.24
Asset Writedown & Restructuring Costs
34.2543.62.26--
Loss (Gain) From Sale of Investments
-1.52-2.26-2.72-0.43-
Stock-Based Compensation
44.942.631.7126.1715.66
Other Operating Activities
-5.91-27.1-2.38-83.6926.59
Change in Accounts Receivable
-13.75-8.89-19.4-19.9-12.67
Change in Inventory
1.84-1.84-1.070.14-0.61
Change in Accounts Payable
3.95-5.388.952.79-1.56
Change in Other Net Operating Assets
99.788.7946.5512.8715.46
Operating Cash Flow
348.2219.82219.39144.4798.56
Operating Cash Flow Growth
58.40%0.20%51.86%46.58%-
Capital Expenditures
-0.31-1.15-0.31-0.17-0.3
Cash Acquisitions
--33.07-36.97--
Sale (Purchase) of Intangibles
-34.25-26.5--40-100
Investment in Securities
-5.09-6.76-9.16-101.66-
Investing Cash Flow
-39.65-67.48-46.44-141.83-100.3
Long-Term Debt Issued
--200-200
Long-Term Debt Repaid
-16.25-15-201.25-2-200.5
Net Debt Issued (Repaid)
-16.25-15-1.25-2-0.5
Issuance of Common Stock
10.216.55.068.8439.37
Repurchase of Common Stock
-3-2.5-100.51--
Other Financing Activities
---8.84--31.45
Financing Cash Flow
-9.05-11-105.556.847.42
Net Cash Flow
299.5141.3467.49.485.68
Free Cash Flow
347.89218.67219.08144.2998.26
Free Cash Flow Growth
59.09%-0.19%51.82%46.85%-
Free Cash Flow Margin
40.06%30.59%37.64%32.95%32.17%
Free Cash Flow Per Share
5.943.783.632.361.66
Cash Interest Paid
14.6917.3220.0516.3619.83
Cash Income Tax Paid
19.8279.6448.2312.652.88
Levered Free Cash Flow
167.57143.91214.3372.97-123.53
Unlevered Free Cash Flow
176.08154.14226.9183.05-110.64
Change in Working Capital
91.82-7.3235.04-4.110.63
Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q